VEGF and Bcl-2 interact via MAPKs signaling pathway in the response to hypoxia in neuroblastoma

Cellular and Molecular Neurobiology

Volumn 29, Issue 3, 2009, Pages 391-401

  Wang, Duoduo ^a   Weng, Qinjie ^a   Zhang, Lei ^a   He, Qiaojun ^a   Yang, Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bcl 2; Hypoxia; MAPKs; VEGF

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CONTROL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOXIA; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRESS; TIME; TUMOR CELL; TUMOR GROWTH;

BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL HYPOXIA; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NEUROBLASTOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349176383     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-008-9331-9     Document Type: Article

References (48)

1. JM Adams S Cory 2007 The Bcl-2 apoptotic switch in cancer development and therapy Oncogene 26 1324 1337 10.1038/sj.onc.1210220
2. A Alfranca MD Gutiérrez A Vara J Aragonés F Vidal MO Landázuri 2002 c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription Mol Cell Biol 22 12 22 10.1128/MCB.22.1.12-22.2002
3. S Anai S Goodison K Shiverick Y Hirao BD Brown CJ Rosser 2007 Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts Mol Cancer Ther 6 101 111 10.1158/1535-7163.MCT-06-0367
4. BA Ballif J Blenis 2001 Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals Cell Growth Differ 12 397 408
5. FC Barone EA Irving AM Ray JC Lee S Kassis S Kumar AM Badger JJ Legos JA Erhardt EH Ohlstein AJ Hunter DC Harrison K Philpott BR Smith JL Adams AA Parsons 2001 Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia Med Res Rev 21 129 145 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H
6. E Benasciutti G Pagès O Kenzior W Folk F Blasi MP Crippa 2004 MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription Blood 104 256 262 10.1182/blood-2003-08-2661
7. E Berra J Milanini DE Richard M Le Gall F Viñals E Gothié D Roux G Pagès J Pouysségur 2000 Signaling angiogenesis via p42/p44 MAP kinase and hypoxia Biochem Pharmacol 60 1171 1178 10.1016/S0006-2952(00) 00423-8
8. PE Bickler PH Donohoe LT Buck 2000 Hypoxia-induced silencing of NMDA receptors in turtle neurons J Neurosci 20 3522 3528
9. S Boldt UH Weidle W Kolch 2002 The role of MAPK pathways in the action of chemotherapeutic drugs Carcinogenesis 23 1831 1838 10.1093/carcin/23.11.1831
10. A Brunet D Roux P Lenormand S Dowd S Keyse J Pouysségur 1999 Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry EMBO J 18 664 674 10.1093/emboj/18.3.664
11. TV Byzova CK Goldman N Pampori KA Thomas A Bett SJ Shattil EF Plow 2000 A mechanism for modulation of cellular responses to VEGF: activation of the integrins Mol Cell 6 851 860
12. WS Choi DS Eom BS Han WK Kim BH Han EJ Choi TH Oh GJ Markelonis JW Cho YJ Oh 2004 Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons J Biol Chem 279 20451 20460 10.1074/jbc.M311164200
13. PW Conrad RT Rust J Han DE Millhorn D Beitner-Johnson 1999 Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells J Biol Chem 274 23570 23576 10.1074/jbc.274.33.23570
14. M Dewil VF dela Cruz L Van Den Bosch W Robberecht 2007 Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death Neurobiol Dis 26 2 332 341 10.1016/j.nbd.2006.12.023
15. S Dias SV Shmelkov G Lam S Rafii 2002 VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition Blood 99 2532 2540 10.1182/blood.V99.7.2532
16. H Feng H Xiang YW Mao J Wang JP Liu XQ Huang Y Liu SJ Liu C Luo XJ Zhang Y Liu DW Li 2004 Human Bcl-2 activates ERK signaling pathway to regulate activating protein-1, lens epithelium-derived growth factor and downstream genes Oncogene 23 7310 7321 10.1038/sj.onc.1208041
17. A Fernandez T Udagawa C Schwesinger W Beecken E Achilles-Gerte T McDonnell R D'Amato 2001 Angiogenic potential of prostate carcinoma cells overexpressing bcl-2 J Natl Cancer Inst 93 208 213 10.1093/jnci/93.3.208
18. N Ferrara HP Gerber J LeCouter 2003 The biology of VEGF and its receptors Nat Med 9 669 676 10.1038/nm0603-669
19. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6 10.1093/jnci/82.1.4
20. G Helmlinger F Yuan M Dellian RK Jain 1997 Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat Med 3 177 182 10.1038/nm0297-177
21. ST Hou X Xie A Baggley DS Park G Chen T Walker 2002 Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis J Biol Chem 277 48764 48770 10.1074/jbc.M206336200
22. K Jin XO Mao Y Zhu DA Greenberg 2002 MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad J Neurochem 80 119 125 10.1046/j.0022-3042. 2001.00678.x
23. E Junn MM Mouradian 2001 Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases J Neurochem 78 374 383 10.1046/j.1471-4159.2001.00425. x
24. E Kilic U Kilic Y Wang CL Bassetti HH Marti DM Hermann 2006 The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia FASEB J 20 1185 1187 10.1096/fj.05-4829fje
25. DS Kim SY Kim JE Lee SB Kwon YH Joo SW Youn KC Park 2003 Sphingosine-1-phosphate-induced ERK activation protects human melanocytes from UVB-induced apoptosis Arch Pharm Res 26 739 746
26. M Kraemer R Tournaire V Dejong N Montreau D Briane C Derbin B Binétruy 1999 Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors Cell Growth Differ 10 193 200
27. H Le-Niculescu E Bonfoco Y Kasuya F Claret DR Green M Karin 1999 Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death Mol Cell Biol 19 751 763
28. K Mackay D Mochly-Rosen 1999 An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia J Biol Chem 274 6272 6279 10.1074/jbc.274.10.6272
29. G Makin C Dive 2001 Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy? Breast Cancer Res 3 150 153 10.1186/bcr289
30. JL Martin M Avkiran RA Quinlan P Cohen MS Marber 2001 Antiischemic effects of SB203580 are mediated through the inhibition of p38alpha mitogen-activated protein kinase: Evidence from ectopic expression of an inhibition-resistant kinase Circ Res 89 750 752 10.1161/hh2101.099504
31. D Maulik QM Ashraf OP Mishra M Delivoria-Papadopoulos 2008 Activation of p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of guinea pig fetus at term: Role of nitric oxide Neurosci Lett 439 94 99 10.1016/j.neulet.2008.02.037
32. B Meister F Grünebach F Bautz W Brugger FM Fink L Kanz R Möhle 1999 Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma Eur J Cancer 35 445 449 10.1016/S0959-8049(98)00387-6
33. G Neufeld T Cohen S Gengrinovitch Z Poltorak 1999 Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 9 22
34. V Poulaki W Qin AM Joussen P Hurlbut SJ Wiegand J Rudge GD Yancopoulos AP Adamis 2002 Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF J Clin Invest 109 805 815
35. D Qian HY Lin HM Wang X Zhang DL Liu QL Li C Zhu 2004 Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells Biol Reprod 70 1822 1827 10.1095/biolreprod.103.025031
36. CJ Rosser AO Reyes F Vakar-Lopez LB Levy DA Kuban DC Hoover AK Lee LL Pisters 2003 Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma Int J Radiat Oncol Biol Phys 56 1 6 10.1016/S0360-3016(02)04468-1
37. HR Schlesinger JM Gerson PS Moorhead H Maguire K Hummeler 1976 Establishment and characterization of human neuroblastoma cell lines Cancer Res 36 3000 3094
38. GL Semenza 2001 HIF-1 and mechanisms of hypoxia sensing Curr Opin Cell Biol 13 167 171 10.1016/S0955-0674(00)00194-0
39. M Shakibaei G Schulze-Tanzil P de Souza T John M Rahmanzadeh R Rahmanzadeh HJ Merker 2001 Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes J Biol Chem 276 13289 13294 10.1074/jbc.M010859200
40. H Takahashi M Shibuya 2005 The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Clin Sci (Lond) 109 227 241 10.1042/CS20040370
41. H Tokuda K Hirade X Wang Y Oiso O Kozawa 2003 Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts J Endocrinol 177 101 107 10.1677/joe.0.1770101
42. D Trisciuoglio A Iervolino A Candiloro G Fibbi M Fanciulli U Zangemeister-Wittke G Zupi D Del Bufalo 2004 bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity J Biol Chem 279 6737 6745 10.1074/jbc.M308938200
43. D Trisciuoglio A Iervolino G Zupi D Del Bufalo 2005 Involvement of PI3 K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells Mol Biol Cell 16 4153 4162 10.1091/mbc.E04-12-1087
44. K Yokoi IJ Fidler 2004 Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine Clin Cancer Res 10 2299 2306 10.1158/1078-0432.CCR-03-0488
45. I Zachary 2003 VEGF signalling: integration and multi-tasking in endothelial cell biology Biochem Soc Trans 31 Pt 6 1171 1177
46. BD Zeitlin E Joo Z Dong K Warner G Wang Z Nikolovska-Coleska S Wang JE Nör 2006 Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2 Cancer Res 66 8698 8706 10.1158/0008-5472.CAN-05-3691
47. Y Zhang M Furumura E Morita 2008 Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165 Growth Factors 26 125 131 10.1080/08977190802105909
48. X Zhu M Mei HG Lee Y Wang J Han G Perry MA Smith 2005 P38 activation mediates amyloid-beta cytotoxicity Neurochem Res 30 791 796 10.1007/s11064-005- 6872-x